ROGERS MICHAEL W 4
4 · Akebia Therapeutics, Inc. · Filed Jun 3, 2021
Insider Transaction Report
Form 4
ROGERS MICHAEL W
Director
Transactions
- Award
Common Stock
2021-06-02+13,700→ 52,329 total - Award
Stock Option (Right to buy)
2021-06-02+20,100→ 20,100 totalExercise: $3.37From: 2022-06-02Exp: 2031-06-02→ Common Stock (20,100 underlying)
Footnotes (2)
- [F1]The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended (the "2014 Plan"), as provided by the Issuer's Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.
- [F2]The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2014 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer.